The role of the ERMP1 protein in cancer proliferation and progression through the PI3K/AKT/mTOR/β-catenin signaling pathways has been identified as a promising therapeutic strategy for treating various types of cancer [6,7]. This evidence concerns the gene MTOR and cancer.